Asset Details
Do you wish to reserve the book?
RTS,S malaria vaccine pilots in three African countries
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
RTS,S malaria vaccine pilots in three African countries
Do you wish to request the book?
RTS,S malaria vaccine pilots in three African countries
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
RTS,S malaria vaccine pilots in three African countries
2019
Overview
For the pilot studies, vaccine manufacturer GlaxoSmithKline is providing up to 10 million doses of the vaccine, the countries' ministries of health will lead the vaccine introduction through their national immunisation programmes, and WHO will provide scientific and technical leadership. The vaccine will be given to young children starting at 5 and 6 months of age and up to 2 years, in areas where malaria is high burden and young children are at highest risk of dying from the disease, in four doses, Felicitas Zawaira, Director of Family and Reproductive Health in the WHO African Region, said at a press conference on April 23. The vaccine could also help to accelerate the realisation of the WHO Global Technical Strategy for Malaria 2016–2030, which aims to reduce the incidence of malaria by at least 90%, reduce malaria mortality rates by at least 90%, eliminate malaria in at least 35 countries, prevent a resurgence of malaria in all countries that are malaria-free, achieve near-term milestones for 2020 (including reductions in related incidence and mortalities of at least 40%) and the elimination of malaria in at least ten countries, and harness innovation and expand research.
Publisher
Elsevier Ltd,Elsevier Limited
